Danaher CorporationDHRNYSE
Loading
A large-scale business, with solid profitability priced at a premium.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.
Comprehensive financial statement data for deep analysis
| Metric | Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 |
|---|---|---|---|---|---|
| Return on Equity | - | - | - | - | - |
| Return on Invested Capital | - | - | - | - | - |
| Gross Margin | 61.0% | 60.8%↓0.3% | 58.7%↓3.3% | 59.5%↑1.3% | 60.9%↑2.4% |
| Operating Margin | 27.3% | 28.3%↑3.5% | 22.1%↓21.9% | 21.7%↓1.7% | 20.9%↓3.7% |
| Net Margin | 21.8% | 27.1%↑23.9% | 19.9%↓26.3% | 16.3%↓18.1% | 14.7%↓9.9% |
| Earnings Yield | - | - | - | - | - |